Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts

Last Updated: July 3, 2020

DrugPatentWatch Database Preview

Patent: 9,498,539

» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,498,539
Title:Affinity-based controlled release system
Abstract: Prolonged or extended release of bioactive protein is achieved using an affinity-based approach which exploits the specific binding of Src homology 3 (SH3) domain with short proline-rich peptides. Specifically, methylcellulose was modified with SH3-binding peptides (MC-peptide) with either a weak affinity or strong affinity for SH3. Controlled release of chondroitinase ABC (ChABC) is also described.
Inventor(s): Shoichet; Molly Sandra (Toronto, CA), Vulic; Katarina (Oakville, CA)
Application Number:13/728,946
Patent Claims:see list of patent claims

Details for Patent 9,498,539

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Ferring Pharmaceuticals Inc. MENOPUR menotropins KIT 021663 1 2004-10-29   Start Trial 2040-03-30 search
Ferring MENOPUR menotropins (fsh;lh) INJECTABLE;SUBCUTANEOUS 021663 001 2006-03-20   Start Trial 2040-03-30 RX search
Ferring BRAVELLE urofollitropin INJECTABLE; SUBCUTANEOUS 021484 001 2002-12-19   Start Trial 2040-03-30 RX search
Ferring BRAVELLE urofollitropin INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS 021289 001 2002-05-06   Start Trial 2040-03-30 DISCN search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.